Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1484574

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1484574

Global Drug Treatment for Respiratory Disease Market Insights, Forecast to 2030

PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Drug Treatment for Respiratory Disease Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 Asthma
    • 1.2.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 1.2.4 Lung Cancer
    • 1.2.5 Other Diseases
  • 1.3 Market by Application
    • 1.3.1 Global Drug Treatment for Respiratory Disease Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Drug Treatment for Respiratory Disease Market Perspective (2019-2030)
  • 2.2 Global Drug Treatment for Respiratory Disease Growth Trends by Region
    • 2.2.1 Global Drug Treatment for Respiratory Disease Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Drug Treatment for Respiratory Disease Historic Market Size by Region (2019-2024)
    • 2.2.3 Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030)
  • 2.3 Drug Treatment for Respiratory Disease Market Dynamics
    • 2.3.1 Drug Treatment for Respiratory Disease Industry Trends
    • 2.3.2 Drug Treatment for Respiratory Disease Market Drivers
    • 2.3.3 Drug Treatment for Respiratory Disease Market Challenges
    • 2.3.4 Drug Treatment for Respiratory Disease Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Drug Treatment for Respiratory Disease by Players
    • 3.1.1 Global Drug Treatment for Respiratory Disease Revenue by Players (2019-2024)
    • 3.1.2 Global Drug Treatment for Respiratory Disease Revenue Market Share by Players (2019-2024)
  • 3.2 Global Drug Treatment for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Drug Treatment for Respiratory Disease, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Drug Treatment for Respiratory Disease Market Concentration Ratio
    • 3.4.1 Global Drug Treatment for Respiratory Disease Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drug Treatment for Respiratory Disease Revenue in 2023
  • 3.5 Global Key Players of Drug Treatment for Respiratory Disease Head office and Area Served
  • 3.6 Global Key Players of Drug Treatment for Respiratory Disease, Product and Application
  • 3.7 Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Treatment for Respiratory Disease Breakdown Data by Type

  • 4.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Type (2019-2024)
  • 4.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030)

5 Drug Treatment for Respiratory Disease Breakdown Data by Application

  • 5.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Application (2019-2024)
  • 5.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 6.2 North America Drug Treatment for Respiratory Disease Market Size by Type
    • 6.2.1 North America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 6.2.2 North America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 6.2.3 North America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 6.3 North America Drug Treatment for Respiratory Disease Market Size by Application
    • 6.3.1 North America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 6.3.2 North America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 6.3.3 North America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 6.4 North America Drug Treatment for Respiratory Disease Market Size by Country
    • 6.4.1 North America Drug Treatment for Respiratory Disease Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
    • 6.4.3 North America Drug Treatment for Respiratory Disease Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 7.2 Europe Drug Treatment for Respiratory Disease Market Size by Type
    • 7.2.1 Europe Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 7.2.2 Europe Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 7.2.3 Europe Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 7.3 Europe Drug Treatment for Respiratory Disease Market Size by Application
    • 7.3.1 Europe Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 7.3.2 Europe Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 7.3.3 Europe Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 7.4 Europe Drug Treatment for Respiratory Disease Market Size by Country
    • 7.4.1 Europe Drug Treatment for Respiratory Disease Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
    • 7.4.3 Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia
    • 7.4.9 Nordic Countries

8 China

  • 8.1 China Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 8.2 China Drug Treatment for Respiratory Disease Market Size by Type
    • 8.2.1 China Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 8.2.2 China Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 8.2.3 China Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 8.3 China Drug Treatment for Respiratory Disease Market Size by Application
    • 8.3.1 China Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 8.3.2 China Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 8.3.3 China Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 9.2 Asia Drug Treatment for Respiratory Disease Market Size by Type
    • 9.2.1 Asia Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 9.2.2 Asia Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 9.2.3 Asia Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 9.3 Asia Drug Treatment for Respiratory Disease Market Size by Application
    • 9.3.1 Asia Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 9.3.2 Asia Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 9.3.3 Asia Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 9.4 Asia Drug Treatment for Respiratory Disease Market Size by Region
    • 9.4.1 Asia Drug Treatment for Respiratory Disease Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Drug Treatment for Respiratory Disease Market Size by Region (2019-2024)
    • 9.4.3 Asia Drug Treatment for Respiratory Disease Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 GSK
    • 11.1.1 GSK Company Details
    • 11.1.2 GSK Business Overview
    • 11.1.3 GSK Drug Treatment for Respiratory Disease Introduction
    • 11.1.4 GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.1.5 GSK Recent Development
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Company Details
    • 11.2.2 AstraZeneca Business Overview
    • 11.2.3 AstraZeneca Drug Treatment for Respiratory Disease Introduction
    • 11.2.4 AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.2.5 AstraZeneca Recent Development
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Company Details
    • 11.3.2 Boehringer Ingelheim Business Overview
    • 11.3.3 Boehringer Ingelheim Drug Treatment for Respiratory Disease Introduction
    • 11.3.4 Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.3.5 Boehringer Ingelheim Recent Development
  • 11.4 Novartis
    • 11.4.1 Novartis Company Details
    • 11.4.2 Novartis Business Overview
    • 11.4.3 Novartis Drug Treatment for Respiratory Disease Introduction
    • 11.4.4 Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.4.5 Novartis Recent Development
  • 11.5 Mylan
    • 11.5.1 Mylan Company Details
    • 11.5.2 Mylan Business Overview
    • 11.5.3 Mylan Drug Treatment for Respiratory Disease Introduction
    • 11.5.4 Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.5.5 Mylan Recent Development
  • 11.6 Vertex Pharmaceuticals
    • 11.6.1 Vertex Pharmaceuticals Company Details
    • 11.6.2 Vertex Pharmaceuticals Business Overview
    • 11.6.3 Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Introduction
    • 11.6.4 Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.6.5 Vertex Pharmaceuticals Recent Development
  • 11.7 F. Hoffman La Roche
    • 11.7.1 F. Hoffman La Roche Company Details
    • 11.7.2 F. Hoffman La Roche Business Overview
    • 11.7.3 F. Hoffman La Roche Drug Treatment for Respiratory Disease Introduction
    • 11.7.4 F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.7.5 F. Hoffman La Roche Recent Development
  • 11.8 Teva Pharmaceuticals
    • 11.8.1 Teva Pharmaceuticals Company Details
    • 11.8.2 Teva Pharmaceuticals Business Overview
    • 11.8.3 Teva Pharmaceuticals Drug Treatment for Respiratory Disease Introduction
    • 11.8.4 Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.8.5 Teva Pharmaceuticals Recent Development
  • 11.9 Cipla
    • 11.9.1 Cipla Company Details
    • 11.9.2 Cipla Business Overview
    • 11.9.3 Cipla Drug Treatment for Respiratory Disease Introduction
    • 11.9.4 Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.9.5 Cipla Recent Development
  • 11.10 Fibrogen
    • 11.10.1 Fibrogen Company Details
    • 11.10.2 Fibrogen Business Overview
    • 11.10.3 Fibrogen Drug Treatment for Respiratory Disease Introduction
    • 11.10.4 Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.10.5 Fibrogen Recent Development
  • 11.11 Liminal Biosciences
    • 11.11.1 Liminal Biosciences Company Details
    • 11.11.2 Liminal Biosciences Business Overview
    • 11.11.3 Liminal Biosciences Drug Treatment for Respiratory Disease Introduction
    • 11.11.4 Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.11.5 Liminal Biosciences Recent Development
  • 11.12 PharmAkea Therapeutics
    • 11.12.1 PharmAkea Therapeutics Company Details
    • 11.12.2 PharmAkea Therapeutics Business Overview
    • 11.12.3 PharmAkea Therapeutics Drug Treatment for Respiratory Disease Introduction
    • 11.12.4 PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.12.5 PharmAkea Therapeutics Recent Development
  • 11.13 IQVIA
    • 11.13.1 IQVIA Company Details
    • 11.13.2 IQVIA Business Overview
    • 11.13.3 IQVIA Drug Treatment for Respiratory Disease Introduction
    • 11.13.4 IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.13.5 IQVIA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 Asthma
    • 1.2.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 1.2.4 Lung Cancer
    • 1.2.5 Other Diseases
  • 1.3 Market by Application
    • 1.3.1 Global Drug Treatment for Respiratory Disease Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Drug Treatment for Respiratory Disease Market Perspective (2019-2030)
  • 2.2 Global Drug Treatment for Respiratory Disease Growth Trends by Region
    • 2.2.1 Global Drug Treatment for Respiratory Disease Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Drug Treatment for Respiratory Disease Historic Market Size by Region (2019-2024)
    • 2.2.3 Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030)
  • 2.3 Drug Treatment for Respiratory Disease Market Dynamics
    • 2.3.1 Drug Treatment for Respiratory Disease Industry Trends
    • 2.3.2 Drug Treatment for Respiratory Disease Market Drivers
    • 2.3.3 Drug Treatment for Respiratory Disease Market Challenges
    • 2.3.4 Drug Treatment for Respiratory Disease Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Drug Treatment for Respiratory Disease by Players
    • 3.1.1 Global Drug Treatment for Respiratory Disease Revenue by Players (2019-2024)
    • 3.1.2 Global Drug Treatment for Respiratory Disease Revenue Market Share by Players (2019-2024)
  • 3.2 Global Drug Treatment for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Drug Treatment for Respiratory Disease, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Drug Treatment for Respiratory Disease Market Concentration Ratio
    • 3.4.1 Global Drug Treatment for Respiratory Disease Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drug Treatment for Respiratory Disease Revenue in 2023
  • 3.5 Global Key Players of Drug Treatment for Respiratory Disease Head office and Area Served
  • 3.6 Global Key Players of Drug Treatment for Respiratory Disease, Product and Application
  • 3.7 Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Treatment for Respiratory Disease Breakdown Data by Type

  • 4.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Type (2019-2024)
  • 4.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030)

5 Drug Treatment for Respiratory Disease Breakdown Data by Application

  • 5.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Application (2019-2024)
  • 5.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 6.2 North America Drug Treatment for Respiratory Disease Market Size by Type
    • 6.2.1 North America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 6.2.2 North America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 6.2.3 North America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 6.3 North America Drug Treatment for Respiratory Disease Market Size by Application
    • 6.3.1 North America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 6.3.2 North America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 6.3.3 North America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 6.4 North America Drug Treatment for Respiratory Disease Market Size by Country
    • 6.4.1 North America Drug Treatment for Respiratory Disease Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
    • 6.4.3 North America Drug Treatment for Respiratory Disease Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 7.2 Europe Drug Treatment for Respiratory Disease Market Size by Type
    • 7.2.1 Europe Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 7.2.2 Europe Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 7.2.3 Europe Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 7.3 Europe Drug Treatment for Respiratory Disease Market Size by Application
    • 7.3.1 Europe Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 7.3.2 Europe Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 7.3.3 Europe Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 7.4 Europe Drug Treatment for Respiratory Disease Market Size by Country
    • 7.4.1 Europe Drug Treatment for Respiratory Disease Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
    • 7.4.3 Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia
    • 7.4.9 Nordic Countries

8 China

  • 8.1 China Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 8.2 China Drug Treatment for Respiratory Disease Market Size by Type
    • 8.2.1 China Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 8.2.2 China Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 8.2.3 China Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 8.3 China Drug Treatment for Respiratory Disease Market Size by Application
    • 8.3.1 China Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 8.3.2 China Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 8.3.3 China Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 9.2 Asia Drug Treatment for Respiratory Disease Market Size by Type
    • 9.2.1 Asia Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 9.2.2 Asia Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 9.2.3 Asia Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 9.3 Asia Drug Treatment for Respiratory Disease Market Size by Application
    • 9.3.1 Asia Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 9.3.2 Asia Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 9.3.3 Asia Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 9.4 Asia Drug Treatment for Respiratory Disease Market Size by Region
    • 9.4.1 Asia Drug Treatment for Respiratory Disease Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Drug Treatment for Respiratory Disease Market Size by Region (2019-2024)
    • 9.4.3 Asia Drug Treatment for Respiratory Disease Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 GSK
    • 11.1.1 GSK Company Details
    • 11.1.2 GSK Business Overview
    • 11.1.3 GSK Drug Treatment for Respiratory Disease Introduction
    • 11.1.4 GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.1.5 GSK Recent Development
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Company Details
    • 11.2.2 AstraZeneca Business Overview
    • 11.2.3 AstraZeneca Drug Treatment for Respiratory Disease Introduction
    • 11.2.4 AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.2.5 AstraZeneca Recent Development
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Company Details
    • 11.3.2 Boehringer Ingelheim Business Overview
    • 11.3.3 Boehringer Ingelheim Drug Treatment for Respiratory Disease Introduction
    • 11.3.4 Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.3.5 Boehringer Ingelheim Recent Development
  • 11.4 Novartis
    • 11.4.1 Novartis Company Details
    • 11.4.2 Novartis Business Overview
    • 11.4.3 Novartis Drug Treatment for Respiratory Disease Introduction
    • 11.4.4 Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.4.5 Novartis Recent Development
  • 11.5 Mylan
    • 11.5.1 Mylan Company Details
    • 11.5.2 Mylan Business Overview
    • 11.5.3 Mylan Drug Treatment for Respiratory Disease Introduction
    • 11.5.4 Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.5.5 Mylan Recent Development
  • 11.6 Vertex Pharmaceuticals
    • 11.6.1 Vertex Pharmaceuticals Company Details
    • 11.6.2 Vertex Pharmaceuticals Business Overview
    • 11.6.3 Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Introduction
    • 11.6.4 Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.6.5 Vertex Pharmaceuticals Recent Development
  • 11.7 F. Hoffman La Roche
    • 11.7.1 F. Hoffman La Roche Company Details
    • 11.7.2 F. Hoffman La Roche Business Overview
    • 11.7.3 F. Hoffman La Roche Drug Treatment for Respiratory Disease Introduction
    • 11.7.4 F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.7.5 F. Hoffman La Roche Recent Development
  • 11.8 Teva Pharmaceuticals
    • 11.8.1 Teva Pharmaceuticals Company Details
    • 11.8.2 Teva Pharmaceuticals Business Overview
    • 11.8.3 Teva Pharmaceuticals Drug Treatment for Respiratory Disease Introduction
    • 11.8.4 Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.8.5 Teva Pharmaceuticals Recent Development
  • 11.9 Cipla
    • 11.9.1 Cipla Company Details
    • 11.9.2 Cipla Business Overview
    • 11.9.3 Cipla Drug Treatment for Respiratory Disease Introduction
    • 11.9.4 Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.9.5 Cipla Recent Development
  • 11.10 Fibrogen
    • 11.10.1 Fibrogen Company Details
    • 11.10.2 Fibrogen Business Overview
    • 11.10.3 Fibrogen Drug Treatment for Respiratory Disease Introduction
    • 11.10.4 Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.10.5 Fibrogen Recent Development
  • 11.11 Liminal Biosciences
    • 11.11.1 Liminal Biosciences Company Details
    • 11.11.2 Liminal Biosciences Business Overview
    • 11.11.3 Liminal Biosciences Drug Treatment for Respiratory Disease Introduction
    • 11.11.4 Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.11.5 Liminal Biosciences Recent Development
  • 11.12 PharmAkea Therapeutics
    • 11.12.1 PharmAkea Therapeutics Company Details
    • 11.12.2 PharmAkea Therapeutics Business Overview
    • 11.12.3 PharmAkea Therapeutics Drug Treatment for Respiratory Disease Introduction
    • 11.12.4 PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.12.5 PharmAkea Therapeutics Recent Development
  • 11.13 IQVIA
    • 11.13.1 IQVIA Company Details
    • 11.13.2 IQVIA Business Overview
    • 11.13.3 IQVIA Drug Treatment for Respiratory Disease Introduction
    • 11.13.4 IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
    • 11.13.5 IQVIA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer

List of Tables

Table 1. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Asthma

Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)

Table 4. Key Players of Lung Cancer

Table 5. Key Players of Other Diseases

Table 6. Global Drug Treatment for Respiratory Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Drug Treatment for Respiratory Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Drug Treatment for Respiratory Disease Market Share by Region (2019-2024)

Table 10. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Drug Treatment for Respiratory Disease Market Share by Region (2025-2030)

Table 12. Drug Treatment for Respiratory Disease Market Trends

Table 13. Drug Treatment for Respiratory Disease Market Drivers

Table 14. Drug Treatment for Respiratory Disease Market Challenges

Table 15. Drug Treatment for Respiratory Disease Market Restraints

Table 16. Global Drug Treatment for Respiratory Disease Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Drug Treatment for Respiratory Disease Market Share by Players (2019-2024)

Table 18. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)

Table 19. Global Drug Treatment for Respiratory Disease Industry Ranking 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Drug Treatment for Respiratory Disease Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Drug Treatment for Respiratory Disease, Headquarters and Area Served

Table 22. Global Key Players of Drug Treatment for Respiratory Disease, Product and Application

Table 23. Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2019-2024)

Table 27. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2025-2030)

Table 29. Global Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2019-2024)

Table 31. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2025-2030)

Table 33. North America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Drug Treatment for Respiratory Disease Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)

Table 65. GSK Company Details

Table 66. GSK Business Overview

Table 67. GSK Drug Treatment for Respiratory Disease Product

Table 68. GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 69. GSK Recent Development

Table 70. AstraZeneca Company Details

Table 71. AstraZeneca Business Overview

Table 72. AstraZeneca Drug Treatment for Respiratory Disease Product

Table 73. AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 74. AstraZeneca Recent Development

Table 75. Boehringer Ingelheim Company Details

Table 76. Boehringer Ingelheim Business Overview

Table 77. Boehringer Ingelheim Drug Treatment for Respiratory Disease Product

Table 78. Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 79. Boehringer Ingelheim Recent Development

Table 80. Novartis Company Details

Table 81. Novartis Business Overview

Table 82. Novartis Drug Treatment for Respiratory Disease Product

Table 83. Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 84. Novartis Recent Development

Table 85. Mylan Company Details

Table 86. Mylan Business Overview

Table 87. Mylan Drug Treatment for Respiratory Disease Product

Table 88. Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 89. Mylan Recent Development

Table 90. Vertex Pharmaceuticals Company Details

Table 91. Vertex Pharmaceuticals Business Overview

Table 92. Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Product

Table 93. Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 94. Vertex Pharmaceuticals Recent Development

Table 95. F. Hoffman La Roche Company Details

Table 96. F. Hoffman La Roche Business Overview

Table 97. F. Hoffman La Roche Drug Treatment for Respiratory Disease Product

Table 98. F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 99. F. Hoffman La Roche Recent Development

Table 100. Teva Pharmaceuticals Company Details

Table 101. Teva Pharmaceuticals Business Overview

Table 102. Teva Pharmaceuticals Drug Treatment for Respiratory Disease Product

Table 103. Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 104. Teva Pharmaceuticals Recent Development

Table 105. Cipla Company Details

Table 106. Cipla Business Overview

Table 107. Cipla Drug Treatment for Respiratory Disease Product

Table 108. Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 109. Cipla Recent Development

Table 110. Fibrogen Company Details

Table 111. Fibrogen Business Overview

Table 112. Fibrogen Drug Treatment for Respiratory Disease Product

Table 113. Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 114. Fibrogen Recent Development

Table 115. Liminal Biosciences Company Details

Table 116. Liminal Biosciences Business Overview

Table 117. Liminal Biosciences Drug Treatment for Respiratory Disease Product

Table 118. Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 119. Liminal Biosciences Recent Development

Table 120. PharmAkea Therapeutics Company Details

Table 121. PharmAkea Therapeutics Business Overview

Table 122. PharmAkea Therapeutics Drug Treatment for Respiratory Disease Product

Table 123. PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 124. PharmAkea Therapeutics Recent Development

Table 125. IQVIA Company Details

Table 126. IQVIA Business Overview

Table 127. IQVIA Drug Treatment for Respiratory Disease Product

Table 128. IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 129. IQVIA Recent Development

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Drug Treatment for Respiratory Disease Market Share by Type: 2023 VS 2030

Figure 3. Asthma Features

Figure 4. Chronic Obstructive Pulmonary Disease (COPD) Features

Figure 5. Lung Cancer Features

Figure 6. Other Diseases Features

Figure 7. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Drug Treatment for Respiratory Disease Market Share by Application: 2023 VS 2030

Figure 9. Hospital Pharmacies Case Studies

Figure 10. Retail Pharmacies Case Studies

Figure 11. Online Pharmacies Case Studies

Figure 12. Drug Treatment for Respiratory Disease Report Years Considered

Figure 13. Global Drug Treatment for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Drug Treatment for Respiratory Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Drug Treatment for Respiratory Disease Market Share by Region: 2023 VS 2030

Figure 16. Global Drug Treatment for Respiratory Disease Market Share by Players in 2023

Figure 17. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Drug Treatment for Respiratory Disease Revenue in 2023

Figure 19. North America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)

Figure 21. North America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)

Figure 22. North America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)

Figure 23. United States Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)

Figure 27. Europe Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)

Figure 28. Europe Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)

Figure 29. Germany Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)

Figure 37. China Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)

Figure 38. Asia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)

Figure 40. Asia Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)

Figure 41. Asia Drug Treatment for Respiratory Disease Market Share by Region (2019-2030)

Figure 42. Japan Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)

Figure 52. Brazil Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GSK Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 59. AstraZeneca Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 60. Boehringer Ingelheim Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 61. Novartis Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 62. Mylan Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 63. Vertex Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 64. F. Hoffman La Roche Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 66. Cipla Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 67. Fibrogen Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 68. Liminal Biosciences Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 69. PharmAkea Therapeutics Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 70. IQVIA Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!